Health
Antiviral proves effective at preventing, treating COVID-19 in lab – EurekAlert
Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health tested how the orally administered experimental…
CHAPEL HILL, NC – Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo lab model containing human lung tissue.
Separate phase 2 and 3 clinical trials are ongoing to evaluate EIDD-2801 safety in humans and its effect on viral shedding in COVID-19 patients.
The number of new COVID-19…
-
General22 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General20 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News15 hours agoThe Laundry Lady secures $1M to fuel international expansion